Back
Grace Therapeutics Stock Price Chart
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
GRCE
Grace Therapeutics
Last Price:
$2.47
Seasonality Move:
8.65%
7 Day Trial
ALL ACCESS PASS
$
7
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and GRCE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Grace Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.24 | Buy |
| 20-day SMA: | 2.15 | Buy |
| 50-day SMA: | 2.53 | Sell |
| 200-day SMA: | 3 | Sell |
| 8-day EMA: | 2.28 | Buy |
| 20-day EMA: | 2.24 | Buy |
| 50-day EMA: | 2.51 | Sell |
| 200-day EMA: | 2.94 | Sell |
Grace Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 58.45 | Buy |
| Chaikin Money Flow: | 10543 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2 - 2.42) | Buy |
| Bollinger Bands (100): | (2.41 - 3.85) | Sell |
Grace Therapeutics Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Grace Therapeutics Stock
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 2.49 while GRCE 8-day simple moving average is 2.24, which is a Buy signal.
-
The stock price of GRCE is 2.49 while Grace Therapeutics 20-day SMA is 2.15, which makes it a Buy.
-
Grace Therapeutics 50-day simple moving average is 2.53 while GRCE share price is 2.49, making it a Sell technically.
-
GRCE stock price is 2.49 and Grace Therapeutics 200-day simple moving average is 3.00, creating a Sell signal.
GRCE Technical Analysis vs Fundamental Analysis
Buy
51
Grace Therapeutics (GRCE)
is a Buy
Is Grace Therapeutics a Buy or a Sell?
-
Grace Therapeutics stock is rated a BuyThe current Grace Therapeutics [GRCE] share price is $2.49. The Score for GRCE is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Grace Therapeutics Stock Info
Market Cap:
34.2M
Price in USD:
2.49
Share Volume:
10.5K
Grace Therapeutics 52-Week Range
52-Week High:
4.97
52-Week Low:
1.75
Buy
51
Grace Therapeutics (GRCE)
is a Buy
Grace Therapeutics Share Price Forecast
-
What is the Grace Therapeutics stock price today?The Grace Therapeutics stock price is 2.49 USD today.
-
Will GRCE stock go up or go down?Grace Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Grace Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Grace Therapeutics is not overvalued.
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 2.49 while GRCE 8-day exponential moving average is 2.28, which is a Buy signal.
-
The stock price of GRCE is 2.49 while Grace Therapeutics 20-day EMA is 2.24, which makes it a Buy.
-
Grace Therapeutics 50-day exponential moving average is 2.51 while GRCE share price is 2.49, making it a Sell technically.
-
GRCE stock price is 2.49 and Grace Therapeutics 200-day simple moving average is 2.94, creating a Sell signal.
Fundamental Analysis of Grace Therapeutics
Is Grace Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.22 per share, and an increase next year of $0.38 per share.
Technical Analysis of Grace Therapeutics
Should I short Grace Therapeutics stock?
-
GRCE Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Grace Therapeutics is a Sell
-
Grace Therapeutics Relative Strength Index (RSI) is 58.45, which suggest Grace Therapeutics is overbought
-
The Bollinger Bands (25) for Grace Therapeutics is (2 - 2.42), which suggest Grace Therapeutics is a Sell
-
The Bollinger Bands (100) for Grace Therapeutics is (2.41 - 3.85), which suggest Grace Therapeutics is a Sell
* Grace Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.